rs140389725
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 2P and 7B. PM1BP4_ModerateBP6BS1
The NM_032806.6(POMGNT2):c.488A>G(p.Asn163Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000106 in 1,613,914 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. N163N) has been classified as Likely benign.
Frequency
Consequence
NM_032806.6 missense
Scores
Clinical Significance
Conservation
Publications
- muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- myopathy caused by variation in POMGNT2Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| POMGNT2 | NM_032806.6 | c.488A>G | p.Asn163Ser | missense_variant | Exon 2 of 2 | ENST00000344697.3 | NP_116195.2 | |
| POMGNT2 | NM_001437285.1 | c.488A>G | p.Asn163Ser | missense_variant | Exon 3 of 3 | NP_001424214.1 | ||
| POMGNT2 | XM_011534163.3 | c.488A>G | p.Asn163Ser | missense_variant | Exon 3 of 3 | XP_011532465.1 | ||
| POMGNT2 | XM_017007353.2 | c.488A>G | p.Asn163Ser | missense_variant | Exon 4 of 4 | XP_016862842.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000566 AC: 86AN: 151934Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000131 AC: 33AN: 251364 AF XY: 0.000125 show subpopulations
GnomAD4 exome AF: 0.0000575 AC: 84AN: 1461862Hom.: 0 Cov.: 37 AF XY: 0.0000550 AC XY: 40AN XY: 727224 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000572 AC: 87AN: 152052Hom.: 0 Cov.: 33 AF XY: 0.000565 AC XY: 42AN XY: 74302 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1
Has not been previously published as pathogenic or benign to our knowledge; In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect -
POMGNT2-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at